168 related articles for article (PubMed ID: 36226731)
1. The prognostic marker elastin correlates with epithelial-mesenchymal transition and vimentin-positive fibroblasts in gastric cancer.
Fang T; Zhang L; Yin X; Wang Y; Zhang X; Bian X; Jiang X; Yang S; Xue Y
J Pathol Clin Res; 2023 Jan; 9(1):56-72. PubMed ID: 36226731
[TBL] [Abstract][Full Text] [Related]
2. A prognostic marker LTBP1 is associated with epithelial mesenchymal transition and can promote the progression of gastric cancer.
Jiang X; Yin S; Yin X; Wang Y; Fang T; Yang S; Bian X; Li G; Xue Y; Zhang L
Funct Integr Genomics; 2024 Feb; 24(1):30. PubMed ID: 38358412
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblast expression of glutamine fructose-6-phosphate aminotransferase 2 (GFPT2) is a prognostic marker in gastric cancer.
Yang S; Li G; Yin X; Wang Y; Jiang X; Bian X; Fang T; Yin S; Zhang L; Xue Y
J Pathol Clin Res; 2023 Sep; 9(5):391-408. PubMed ID: 37395335
[TBL] [Abstract][Full Text] [Related]
4. PRRX1 promotes lymph node metastasis of gastric cancer by regulating epithelial-mesenchymal transition.
Yao J; Zhang Y; Xia Y; Zhu C; Wen X; Liu T; Da M
Medicine (Baltimore); 2021 Feb; 100(6):e24674. PubMed ID: 33578599
[TBL] [Abstract][Full Text] [Related]
5. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
[TBL] [Abstract][Full Text] [Related]
7. Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.
Hu Q; Masuda T; Kuramitsu S; Tobo T; Sato K; Kidogami S; Nambara S; Ueda M; Tsuruda Y; Kuroda Y; Ito S; Oki E; Mori M; Mimori K
PLoS One; 2020; 15(10):e0241140. PubMed ID: 33095806
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of vimentin-expressing gastric cancer cells in bone marrow.
Iwatsuki M; Mimori K; Fukagawa T; Ishii H; Yokobori T; Sasako M; Baba H; Mori M
Ann Surg Oncol; 2010 Sep; 17(9):2526-33. PubMed ID: 20358301
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of LKB1 is associated with epithelial-mesenchymal transition and led to an unfavorable prognosis in gastric cancer.
Hu M; Zhao T; Liu J; Zou Z; Xu Q; Gong P; Guo H
Hum Pathol; 2019 Jan; 83():133-139. PubMed ID: 30171989
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of altering epithelial-mesenchymal transition in metastatic lymph nodes of gastric cancer.
Okubo K; Uenosono Y; Arigami T; Yanagita S; Matsushita D; Kijima T; Amatatsu M; Uchikado Y; Kijima Y; Maemura K; Natsugoe S
Gastric Cancer; 2017 Sep; 20(5):802-810. PubMed ID: 28247164
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.
Fan Y; Wang YF; Su HF; Fang N; Zou C; Li WF; Fei ZH
J Hematol Oncol; 2016 Jul; 9(1):57. PubMed ID: 27439973
[TBL] [Abstract][Full Text] [Related]
12. Cyr61/CCN1 overexpression induces epithelial-mesenchymal transition leading to laryngeal tumor invasion and metastasis and poor prognosis.
Liu Y; Zhou YD; Xiao YL; Li MH; Wang Y; Kan X; Li QY; Lu JG; Jin DJ
Asian Pac J Cancer Prev; 2015; 16(7):2659-64. PubMed ID: 25854342
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of EphA2 correlates with epithelial-mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients.
Hou F; Yuan W; Huang J; Qian L; Chen Z; Ge J; Wu S; Chen J; Wang J; Chen Z
Med Oncol; 2012 Dec; 29(4):2691-700. PubMed ID: 22189617
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of Stathmin1 expression and epithelial-mesenchymal transition in curatively resected gastric cancer.
Ke B; Guo XF; Li N; Wu LL; Li B; Zhang RP; Liang H
Mol Clin Oncol; 2019 Feb; 10(2):214-222. PubMed ID: 30680197
[TBL] [Abstract][Full Text] [Related]
15. CD146 expression correlates with epithelial-mesenchymal transition markers and a poor prognosis in gastric cancer.
Liu WF; Ji SR; Sun JJ; Zhang Y; Liu ZY; Liang AB; Zeng HZ
Int J Mol Sci; 2012; 13(5):6399-6406. PubMed ID: 22754372
[TBL] [Abstract][Full Text] [Related]
16. Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer.
Song J; Wei R; Huo S; Gao J; Liu X
Front Immunol; 2022; 13():920512. PubMed ID: 35769483
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Slug expression is useful for predicting lymph node metastasis and survival in patients with gastric cancer.
Lee HH; Lee SH; Song KY; Na SJ; O JH; Park JM; Jung ES; Choi MG; Park CH
BMC Cancer; 2017 Oct; 17(1):670. PubMed ID: 28974196
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of SATB1 correlates with epithelial-mesenchymal transition and lymphatic metastasis in gastric cancer.
Xiao T; Jie Z; Zou J; Fu L
Ann Diagn Pathol; 2023 Feb; 62():152074. PubMed ID: 36495733
[TBL] [Abstract][Full Text] [Related]
19. Elastin is a key factor of tumor development in colorectal cancer.
Li J; Xu X; Jiang Y; Hansbro NG; Hansbro PM; Xu J; Liu G
BMC Cancer; 2020 Mar; 20(1):217. PubMed ID: 32171282
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]